Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPE/3705 stock hub

TPE/3705 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPE/3705is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
14.7B
Taiwan Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPE/3705
In the news

Latest news · TPE/3705

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/E18.6
P25 14.4P50 18P75 31.9
ROE9.4
P25 -16.2P50 0.3P75 9.8
ROIC11.9
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPE/3705 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
237
Groups with data
11
Currency
TWD
Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Taiwan
Country code
TW
Enterprise value
TWD 14.1B
Exchange
Taiwan Stock Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
TW0003705000
Last refreshed
2026-05-10
Market cap
TWD 14.7B
Price
TWD 55.3
Price currency
TWD
Sector
Healthcare
Sic
2834
Symbol
tpe/3705
Website
https://www.yungshingroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
5.37%
EV Earnings
17.85x
EV/EBIT
11.03x
EV/EBITDA
9.05x
EV/FCF
15.23x
EV/Sales
1.76x
FCF yield
6.3%
P/B ratio
1.74x
P/E ratio
18.61x
P/S ratio
1.83x
PE Ratio10 Y
15.96x
PE Ratio3 Y
15.28x
PE Ratio5 Y
14.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
15.14%
EBITDA Margin
18.42%
FCF margin
11.54%
Gross margin
43.48%
Gross Profit
TWD 3.5B
Gross Profit Growth
-5.57%
Gross Profit Growth Q
-15.64%
Gross Profit Growth3 Y
6.16%
Gross Profit Growth5 Y
-0.69%
Net Income
TWD 791.7M
Net Income Growth
-35.5%
Net Income Growth Q
-27.3%
Net Income Growth Years
0%
Net Income Growth3 Y
0.21%
Net Income Growth5 Y
2.41%
Pretax Margin
14.64%
Profit Margin
9.85%
Profitable Years
20
ROA
5.76
Roa5y
5.29
ROCE
12.14
ROE
9.44
Roe5y
11.69
ROIC
11.94
Roic5y
9.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

28
MetricValue
Cagr10y
6.29%
Cagr15y
4.75%
Cagr1y
-13.92%
Cagr3y
11.81%
Cagr5y
9.52%
Div CAGR10
1.84%
Div CAGR3
9.26%
Div CAGR5
8.45%
EPS Growth
-35.55
EPS Growth Q
-27.3
EPS Growth Years
0
EPS Growth3 Y
0.21
EPS Growth5 Y
2.48
FCF Growth
-15.35%
FCF Growth Q
-48.62%
FCF Growth3 Y
1.18%
FCF Growth5 Y
8.42%
OCF Growth
7.79%
OCF Growth Q
-15.95%
OCF Growth10 Y
11.94%
OCF Growth3 Y
11.03%
OCF Growth5 Y
10.06%
Revenue Growth
-4.48x
Revenue Growth Q
-15.54x
Revenue Growth Quarters
1x
Revenue Growth Years
2x
Revenue Growth3 Y
4.57x
Revenue Growth5 Y
0.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
TWD 0.61
Assets
TWD 12.7B
Cash
TWD 2.7B
Current Assets
TWD 7.1B
Current Liabilities
TWD 2.7B
Debt
TWD 1.2B
Debt EBITDA
TWD 0.84
Debt Equity
TWD 0.15
Debt FCF
TWD 1.35
Equity
TWD 8.4B
Interest Coverage
64.92
Liabilities
TWD 4.3B
Long Term Assets
TWD 5.6B
Long Term Liabilities
TWD 1.6B
Net Cash
TWD 1.4B
Net Cash By Market Cap
TWD 9.75
Net Cash Growth
25.04%
Net Debt EBITDA
TWD -0.97
Net Debt Equity
TWD -0.17
Net Debt FCF
TWD -1.55
Tangible Book Value
TWD 7.6B
Tangible Book Value Per Share
TWD 28.53
WACC
4.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.63
Inventory Turnover
1.61
Net Working Capital
TWD 2.1B
Quick ratio
1.57
Working Capital
TWD 4.4B
Working Capital Turnover
TWD 1.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.07%
Dividend Growth
0%
Dividend Growth Years
1%
Dividend per share
TWD 3
Dividend Years
16
Dividend Yield
5.42%
Ex Div Date
2026-06-24
Last Dividend
TWD 3
Payout Frequency
Annual
Payout Ratio
107.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
84.02%
1Y total return
-13.91%
200-day SMA
56.58
3Y total return
39.78%
50-day SMA
54.6
50-day SMA vs 200-day SMA
50under200
5Y total return
57.52%
All Time High
69.9
All Time High Change
-20.89%
All Time High Date
2025-05-07
All Time Low
35.71
All Time Low Change
54.84%
All Time Low Date
2011-09-26
ATR
0.72
Beta
0.08
Beta1y
-0.22
Beta2y
0.02
Ch YTD
-2.98
High
55.5
High52
69.3
High52 Date
2025-05-09
High52ch
-20.2%
Low
55.1
Low52
51.9
Low52 Date
2026-03-23
Low52ch
6.55%
Ma50ch
1.28%
Price vs 200-day SMA
-2.25%
RSI
52.02
RSI Monthly
51.08
RSI Weekly
47.17
Sharpe ratio
-0.52x
Sortino ratio
-0.4
Total Return
5.35%
Tr YTD
-2.98
Tr15y
100.44%
Tr1m
-0.54%
Tr1w
0.36%
Tr3m
-0.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
TWD 1.2B
Operating Income Growth
-13.45
Operating Income Growth Q
-25.68
Operating Income Growth3 Y
18.56
Operating Income Growth5 Y
6.86
Operating margin
15.14

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
163,143,155%
Net Borrowing
208,597,000
Shares Insiders
25.27%
Shares Institutions
10.58%
Shares Out
266,364,924
Shares Qo Q
-0.06%
Shares Yo Y
0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
TWD 919.6M
Average Volume
204,650.1x
Bv Per Share
28.58
CAPEX
TWD -545.2M
Ch10y
15.57
Ch15y
2.95
Ch1m
-0.54
Ch1w
0.36
Ch1y
-18.07
Ch3m
-0.72
Ch3y
21.01
Ch5y
24.97
Ch6m
-1.78
Change
-0.18%
Change From Open
-0.36
Close
55.4
Days Gap
0.18
Depreciation Amortization
263,781,000
Dollar Volume
6,294,190.7
Earnings Date
2026-05-12
EBIT
TWD 1.2B
EBITDA
TWD 1.5B
EPS
TWD 2.97
F Score
5
FCF
TWD 927.9M
FCF EV Yield
6.57x
FCF Per Share
TWD 3.48
Financing CF
-439,386,000
Fiscal Year End
December
Founded
1,952
Graham Number
43.71768
Graham Upside
-20.94
Income Tax
TWD 327.1M
Investing CF
-1,925,289,000
Is Primary Listing
1
Last Earnings Date
2025-11-11
Last Report Date
2026-03-31
Last Split Date
2015-08-28
Last Split Type
Forward
Lynch Fair Value
TWD 14.86
Lynch Upside
-73.13
Ma150
55.97
Ma150ch
-1.2%
Ma20
55.36
Ma20ch
-0.11%
Net CF
-930,545,000
Next Earnings Date
2026-05-12
Open
55.5
P FCF Ratio
15.87
P OCF Ratio
10
Payment Date
2026-07-16
Position In Range
50
Ppne
3,834,021,000
Price Date
2026-05-08
Price EBITDA
TWD 9.95
Ptbv Ratio
1.94
Relative Volume
0.56x
Revenue
8,037,233,000x
SBC By Revenue
0.1x
Share Based Comp
8,303,000
Tax By Revenue
4.07x
Tax Rate
27.8%
Tr6m
-1.78%
Volume
113,819
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TPE/3705 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+5.4%
$3.00 annual per share
Payout ratio
+107.8%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+8.4%
1 consecutive years of growth
Total shareholder yield
+5.4%
Next ex-dividend date: 2026-06-24
Performance

TPE/3705 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-13.9%
S&P 500 1Y: n/a
3Y total return
+39.8%
S&P 500 3Y: n/a
5Y total return
+57.5%
S&P 500 5Y: n/a
10Y total return
+84.0%
S&P 500 10Y: n/a
Ownership

Who owns TPE/3705?

Insider, institutional, and short-interest positioning.

Institutional ownership
+10.6%
Share of float held by funds and institutions
Insider ownership
+25.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

TPE/3705 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.0
Neutral momentum band
Price vs 200-day MA
-2.3%
50/200-day relationship not available
Beta (5Y)
0.08
Less volatile than the market
Sharpe ratio
-0.52
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPE/3705

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/3705 stock rating?

tpe/3705 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/3705 analysis?

The full report lives at /stocks/tpe/3705/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/3705?

The latest report frames tpe/3705 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/3705 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.